Grassley Questions FDA on Avandia Reviewer's Punishment

摘要

Sen. Chuck Grassley (R-Iowa) asked FDA Commissioner Andrew von Eschenbach to respond to allegations that a senior agency scientist was punished for recommending a black box warning on GlaxoSmithKline's (GSK) Type 2 diabetes drug Avandia in 2006.